Skip to main content

Table 1 Clinical information and basal hormonal profiles in three groups

From: Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization

 

A group

B group

C group

P value

No. of patients

657

149

116

NS

Age (years)

30.6 ± 3.3

30.6 ± 3.4

38.5 ± 2.1

< 0.01

Body mass index (kg/m2)

20.3 ± 1.6

22.3 ± 1.7

21.4 ± 1.5

NS

BAFC

12.5 ± 2.1*

11.6 ± 3.2*

4.4 ± 1.9*

< 0.01

FSH (IU/L)

6.12 ± 2.9

6.72 ± 2.8

7.92 ± 2.9

< 0.05

LH (IU/L)

4.6 ± 3.4

4.76 ± 3.3

4.50 ± 2.3

NS

Estradiol (nmol/L)

169.8 ± 131.2

183.10 ± 162.5

192.4 ± 144.1

< 0.01

Endometrial thickness(mm)

11.8 ± 2.7

11.7 ± 2.6

10.93 ± 4.1

NS

Number of ampoules of Gn

35.1 ± 8.9

53.0 ± 15.9

38.1 ± 16.1

< 0.01

Stimulation duration (days)

11.5 ± 1.2

15.3 ± 3.6

9.8 ± 2.6

< 0.01

Peak E2 (nmol/L)

18672.3 ± 5462.4

16769.2 ± 7685.81

9734.8 ± 1245.5

< 0.01

Oocytes retrieved

16.1 ± 7.9

13.7 ± 9.2

7.6 ± 5.3

< 0.01

Embryos transferred

2.3 ± 0.6

2.3 ± 0.5

2.9 ± 0.7

< 0.01

  1. BAFC: basal antral follicle counts. Serum peak E2 was measured in injection HCG day. Values are reported as mean ± SD unless otherwise stated. P < 0.01 was considered statistically significant